Here’s what you should know:
1. Sources related to Mr. Icahn didn’t disclose the reasoning behind or the size of his investment.
2. Mr. Icahn previously held a position in Allergan, which he sold in the first quarter of 2017.
3. The company has been losing value hand over fist since July 2017. To date, Allergan’s stock has dropped 37.68 percent. When news of Mr. Icahn’s investment broke, Allergan’s stock traded up 3.3 percent.
4. Bloomberg said Mr. Icahn and Allergan CEO Brent Saunders have a long established history.
More articles on supply chain:
7 things for ASC leaders to know for Thursday — June 7, 2018
How ASCs are changing as CMS adds procedures, mandates quality reporting
Pain physician faces insurance fraud, perjury after referring workers comp cases to ASC, lab he owned: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.